PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trisodium hexafluoroaluminate | 239-148-8 | 15096-52-3 | - | - | - | - | - | 1 | - | - | - | Details |
|
Trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate
TRILON(R) ES 9910
|
414-130-4 | 119710-96-2 | - | - | - | - | 1 | - | - | - | - | Details |
|
Trisodium N,N-bis(carboxymethyl)-β-alanine
TRILON(R) ES 9851
|
414-070-9 | 129050-62-0 | - | - | - | - | 1 | - | - | - | - | Details |
| Trisodium N-(3-propionato)-L-aspartate | 422-090-4 | 172737-80-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Trisodium nitrilotriacetate | 225-768-6 | 5064-31-3 | - | - | - | - | 2 | - | - | - | - | Details |
| Trisodium tetraoxovanadate | 237-287-9 | 13721-39-6 | - | - | - | - | 1 | - | - | - | - | Details |
| triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol | 603-543-7 | 131983-72-7 | - | - | - | - | - | 1 | - | - | - | Details |
| tritosulfuron (ISO) (containing ≤ 0,02 % 2-amino-4-methoxy-6-(trifluormethyl)-1,3,5-triazine); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % 2-amino-4-methoxy-6-(trifluormethyl)-1,3,5-triazine) | 604-291-0 | 142469-14-5 | - | - | - | - | - | 1 | - | - | - | Details |
| Trizinc bis(orthophosphate) | 231-944-3 | 7779-90-0 | 1 | - | - | - | 1 | - | - | - | - | Details |
| Trizinc diphosphide | 215-244-5 | 1314-84-7 | - | - | - | - | 1 | 1 | - | - | - | Details |
| TW-257 | 434-150-7 | - | - | - | - | - | 1 | - | - | - | - | Details |
| Ulexite | 603-535-3 | 1319-33-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Ulexite (CaNaH12(BO3)5.2H2O), calcined | 296-662-5 | 92908-33-3 | - | - | - | - | 1 | - | - | - | - | Details |
|
Ulexite (CaNaH12(BO3)5.2H2O); Ulexite (CaNaH12(BO3)5.2H2O), calcined
show/hide
|
- | - | - | - | - | - | - | 1 | - | - | - | Details |
| Undecafluorohexanoic acid | 206-196-6 | 307-24-4 | - | 1 | - | - | 1 | - | - | - | - | Details |
|
undecafluorohexanoic acid (PFHxA), its salts and related substances
show/hide
|
- | - | - | - | - | - | 1 | - | - | - | 1 | Details |
|
undecafluorohexanoic acid and its ammonium salt
show/hide
|
- | - | - | - | - | - | - | - | 1 | - | - | Details |
|
undecafluorohexanoic acid and its inorganic salts
show/hide
|
- | - | - | - | - | - | - | 1 | - | - | - | Details |
| undecan-2-one; methyl nonyl ketone | 203-937-5 | 112-12-9 | - | - | - | - | 1 | 1 | - | - | - | Details |
| Undecanonitrile | 218-826-7 | 2244-07-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Undecyl glucoside | 308-766-0 | 98283-67-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Undecylbenzene | 229-806-2 | 6742-54-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Ureylenebis(p-phenylenemethylene-p-phenylene) diisocyanate | 298-531-8 | 93805-48-2 | - | - | - | - | 1 | - | - | - | - | Details |
| Uric acid | 200-720-7 | 69-93-2 | - | - | - | - | 1 | - | - | - | - | Details |
|
UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine
ITC 826 CONCENTRATE
|
422-720-8 | 166242-53-1 | - | - | - | - | 1 | - | - | - | - | Details |
| V159456 | 426-780-6 | - | - | - | - | - | 1 | - | - | - | - | Details |
| Valdipromide | 257-630-6 | 52061-73-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Valeramide | 210-974-0 | 626-97-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Valeronitrile | 203-781-8 | 110-59-8 | - | - | - | - | 1 | - | - | - | - | Details |
| Valnoctamide | 224-033-7 | 4171-13-5 | - | - | - | - | 1 | - | - | - | - | Details |
| Valpromide | 219-394-2 | 2430-27-5 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadate(1-), oxo(phosphato(3-)-kappaO)-, hydrogen, hydrate (2:1) | 424-390-0 | 93280-40-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadate(1-), oxo[phosphato(3-)-.kappa.O]-, hydrogen, hydrate (2:1) | 618-920-1 | 93280-40-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium carbide | 235-122-5 | 12070-10-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium carbide nitride | 601-732-9 | 12069-91-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium dichloride | 234-176-7 | 10580-52-6 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium oxysulphate | 949-084-9 | - | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium tetrachloride | 231-561-1 | 7632-51-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium trichloride | 231-744-6 | 7718-98-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium trichloride oxide | 231-780-2 | 7727-18-6 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadium, oxosulfato-, pentahydrate | 635-023-0 | 12439-96-2 | - | - | - | - | 1 | - | - | - | - | Details |
| Vanadyl diascorbate | 945-749-2 | - | - | - | - | - | 1 | - | - | - | - | Details |
| VANADYL(IV) SULFATE HYDRATE | 677-940-9 | 123334-20-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Vinyl benzoate | 212-214-3 | 769-78-8 | - | - | - | - | 1 | - | - | - | - | Details |
| Vinyl propionate | 203-293-5 | 105-38-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Vinylphosphonic acid | 217-123-2 | 1746-03-8 | - | - | - | - | 1 | - | - | - | - | Details |
| Warfarin | 201-377-6 | 81-81-2 | - | - | - | - | - | 1 | - | - | - | Details |
|
Waste solids, lead silver anode
The slag or residue obtained when lead/silver anodes used in the electrolytic production of zinc are recast. Fusion of the alloys of lead and silver (manganese may also be present) and simultaneous oxidation occur.
|
305-449-9 | 94552-05-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Waste solids, precious metal refining | 308-526-5 | 98072-70-9 | - | - | - | - | 1 | - | - | - | - | Details |
|
Wastes, lead battery reprocessing
Material obtained during the recycling of exhausted lead storage batteries. Consists primarily of oxides and sulfates of lead and lead alloys.
|
305-445-7 | 94551-99-2 | - | - | - | - | 1 | - | - | - | - | Details |